Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Stomach Neoplasms 3 Colorectal Neoplasms 2 Small Cell Lung Carcinoma 1 Prostatic Neoplasms 1 Neoplasms 1 Neoplasm Metastasis 1 Breast Neoplasms 1 Adenocarcinoma 1

Interventions

Etoposide 79 Carboplatin 67 Cisplatin 58 durvalumab 29 Irinotecan 29 Radiotherapy 27 atezolizumab 23 Topotecan 21 anlotinib 19 Nivolumab 15 Drug Therapy 15 Radiosurgery 14 Gemcitabine 13 apatinib 12 Paclitaxel 12 toripalimab 10 Platinum 10 Docetaxel 10 tislelizumab 9 Temozolomide 9 PM 01183 8 pembrolizumab 7 olaparib 7 Magnetic Resonance Spectroscopy 7 Ipilimumab 7 Bevacizumab 7 Albumin-Bound Paclitaxel 7 irinotecan sucrosofate 6 Counseling 6 sintilimab 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Small Cell Lung Carcinoma × polysaccharide-K × Clear all

NCT00546130 2008-09-03

RNCLC

University of Toyama

Phase 2 Unknown

Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡